Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.
Saved in:
| Title: | Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib. |
|---|---|
| Authors: | Wang, Wei1 (AUTHOR), Peng, Siming1 (AUTHOR), Gao, Sihao1 (AUTHOR), Quan, Meiying1 (AUTHOR), Gou, Lijuan1 (AUTHOR), Wang, Changyan1 (AUTHOR), Sun, Zhixing1 (AUTHOR), Li, Zhuo1 (AUTHOR), Lian, Dongmei1 (AUTHOR), Song, Hongmei1 (AUTHOR) songhm1021@126.com |
| Source: | Pediatric Rheumatology. 10/12/2023, Vol. 21 Issue 1, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
